1995年，安利在广州黄埔建成第一家工厂，正式开启中国之旅。30年过去，当年的黄土地已发展为占地14.1万平方米的现代化生产基地，支撑着安利全球 55%的产品供应，服务超过50个国家和地区，是安利全球供应链的重要枢纽。 "我当时在这个生产线上时，装箱的环节需要6个人一起，但现在已经不需要了。"站在广州黄埔的安利工厂里，生产主管张章擎指着流畅运转的自动化设备 对来访的记者介绍变化，他当时在生产线上还需要人工的环节，逐渐都实现了自动化。 行走在工厂的车间，透过透明玻璃，随处可见的是各类自动化的机械臂和设备，传送带上的产品在各个站点完成智能分装、自动装盒、自动打包、激光打 码、X射线检测……这些流水线工作都被机器接管，严谨、精确、可视化。 安利投资中国的30年，是扎根与共生的30年。在安利（中国）三十周年庆典上，安利（中国）总裁余放介绍，30年来，安利已陆续在广州、上海和无锡设立 研发中心，从最初的"搬运工—copy美国总部产品"，到现在，"中国市场已经成为全球创新中心"。 这一路径映射出一家跨国企业在中国市场的深度融入与价 值重构。 "投资中国就是投资未来。"安利全球总裁兼首席执行官迈克尔·尼尔森表示，中国已连续 ...

三十而立,风华正茂。 12月5日,"安利美好生活广场"落成仪式暨安利(中国)三十周年庆典在广州举行,安利董事会联合主席史提 夫.温安洛和德.狄维士、安利全球总裁兼首席执行官迈克尔.尼尔森、安利(中国)总裁余放出席仪式并参 观广场,广州开发区、黄埔区相关领导参加,共同见证安利(中国)的又一发展里程碑,回顾三十年来广州城 市发展所取得的辉煌成就。 "投资中国就是投资未来,与中国同行就是与机遇同行。"迈克尔.尼尔森盛赞安利(中国)30年来"远超预 期"的成就。他直言,若满分100分,他会为安利(中国)打120分。安利将继续深耕中国这片充满机遇的沃土, 目前已启动一项为期五年、总投资21亿元人民币的增资计划。 深化战略级城市合伙人 打造美好生活"广州样本" 扎根广州30年,安利在这片投资沃土汲取养分,以坚定投资、长远布局和全面贡献,持续支持城市发展。 从"后亚运时代"到"十五运会新机遇",广州始终在探索超大城市现代化治理的创新路径。8月18日,广州市 正式批准安利(中国)为"广州城市合伙人.战略合作伙伴"。根据双方战略框架协议,安利以"十五运"为契 机,聚焦大健康产业,通过政企协同发力,重点推进健康广州生态建设、提升 ...

12月5日，"安利美好生活广场" 落成仪式暨安利（中国）三十周年庆典在广州举行，安利董事会联 合主席史提夫·温安洛和德·狄维士、安利全球总裁兼首席执行官迈克尔·尼尔森、安利（中国）总裁余放 出席仪式并参观广场，广州开发区、黄埔区相关领导参加，共同见证安利（中国）的又一发展里程碑， 回顾三十年来广州城市发展所取得的辉煌成就。 "安利美好生活广场"位于广州市黄埔区，由广州开发区管委会、广州市黄埔区人民政府与安利公司 共建。广场毗邻安利广州生产基地，沿扶胥古运河而建，园区种植的100棵异木棉挺立绽放。广场内设 有安利码头、安利剧场、健身步道和运动设施，2.15万平方米的滨水空间成为一片充满活力的户外休闲 活动场所。 活动现场，安利美好生活社群主理人和广州传统美食商户共同打造的美好生活市集，向市民传播健 康、文明、绿色、美好的生活理念。广场"运启繁花"雕塑上镌刻"以花为媒，以水为脉，共筑美好未 来"的标语，记录着这片空间的设计理念与愿景，寓意政企合作共创美好未来，携手共赴广阔前程。 "投资中国就是投资未来，与中国同行就是与机遇同行。"安利全球总裁兼首席执行官迈克尔·尼尔 森盛赞安利（中国）30年来"远超预期"的成就。 ...

我猜，当你看到"CNI长青中国直销"这几个字的时候，心里八成也在打这个鼓。别急，今天咱就别整那些高大上的理论，就像朋友间唠嗑一样，从几个咱们 普通人都能看懂、能去查的方面，一块儿来掂量掂量这个CNI长青中国直销。 CNI长青中国直销靠谱吗13178378259。哎，说真的，现在想找个靠谱的副业或者事业机会，真的跟大海捞针似的。朋友圈里这个那个项目满天飞，个个都 说自己稳赚不赔，听着都心动，可心里头那杆秤就是放不平，老琢磨着："这事儿，它到底靠不靠谱啊？" 第二问：它是个"老字号"吗？—— 看看历史稳不稳 CNI长青中国直销 第一问：它有"身份证"吗？—— 先看合法不合法 这事儿就像咱们找工作，得先看看公司是不是正经注册的，别进了个皮包公司。看CNI长青中国直销也一样，头一件要紧事，就是看它有没有国家认可 的"身份证"——也就是商务部下发的那个《直销经营许可证》。 这个证啊，可不是企业自己说了算的。你得亲自动动手，去"商务部直销行业管理"那个官网上查一查。输入"CNI长青（中国）日用品有限公司"，看看它是 不是在白名单里头。这个动作花不了几分钟，但比听别人说一百句都管用。要是连这个最基本的"身份证"都没有，那后 ...

Core Insights - The 8th China International Import Expo (CIIE) is being held in Shanghai from November 5 to 10, 2023, with the theme "New Era, Shared Future," showcasing 461 new products, technologies, and services across six major exhibition areas [1][3] - CIIE serves as a platform for promoting international economic cooperation and mutual benefits, injecting positive energy into both the Chinese and global economies [1] - Amway, celebrating its 30th anniversary in China, is leveraging CIIE to showcase its health products and solutions, emphasizing its commitment to the Chinese market [1][3] Company Strategy - Amway's Chairman and President, Yu Fang, highlighted the expo's role in enhancing global companies' confidence in investing in China, positioning the country as a strategic market for Amway [3][9] - The company plans to continue increasing its investment in China, focusing on expanding and enhancing its supply chain to contribute to the modernization of the industrial system [3][11] Product Innovation - Amway is using CIIE as a platform to launch innovative products, including those centered around plant nutrients and health solutions, addressing consumer demands for balanced nutrition and health management [4][6] - The company has established a plant research center in Wuxi, China, and is integrating AI technology to develop new health solutions [6][8] Investment Plans - Amway has initiated a five-year investment plan amounting to 2.1 billion RMB, aimed at upgrading its operations in China, including production facilities, digital infrastructure, and experience centers [13] - The investment will also focus on research and development, including organic farming and plant anti-aging research [13] Market Position - Amway has been operating in China for 30 years and has consistently aligned its growth with China's economic development, making it the largest market for the company globally for 22 consecutive years [9][11] - The company views China as a strategic growth engine and is committed to long-term investment in the market, reflecting its belief in the opportunities presented by the Chinese economy [11][13]

Core Insights - The eighth China International Import Expo (CIIE) is held in Shanghai from November 5 to 10, focusing on "New Era, Shared Future" and featuring six major exhibition areas, showcasing 461 new products, technologies, and services, including future industries like low-altitude economy and humanoid robots [1] - CIIE serves as a platform for promoting international economic cooperation and mutual benefits, injecting positive energy into both the Chinese and global economies [1] - Amway, celebrating its 30th anniversary in China, showcases its health products and solutions at CIIE, emphasizing its commitment to enhancing public health and contributing to China's health initiatives [1][4] Amway's Strategic Focus - Amway's chairman highlights the expo's role in providing global companies with insights into the Chinese market, reinforcing Amway's confidence in continued investment in China [4] - The company plans to enhance its investment in China, focusing on extending, expanding, and supplementing its supply chain to contribute to the modernization of China's industrial system [4][12] Health Consumption Trends - The Chinese government's promotion of health consumption is reflected in the popularity of the medical devices and healthcare exhibition area at CIIE, with Amway launching a new vitamin and mineral supplement product, nicknamed "Little Gold Powder," aimed at addressing nutritional imbalances [5] - Amway showcases a range of anti-aging products and health solutions, including those targeting cellular aging, bone density, cognitive health, and skin health, utilizing plant-based nutrients as core ingredients [6] Innovation and R&D - Amway has established a comprehensive local R&D system for traditional Chinese medicine in China, collaborating with various partners to modernize and standardize herbal cultivation [8] - The company has initiated a five-year investment plan of 2.1 billion RMB, focusing on upgrading production facilities, enhancing digital infrastructure, and expanding its experience centers across China [15] Market Position and Future Outlook - Amway has been operating in China for 30 years and has consistently aligned its growth with China's economic development, making it the largest market for Amway globally for 22 consecutive years [9] - The company views China as a strategic growth engine and plans to leverage the country's diverse market opportunities for future investments [12]

Core Insights - The 8th China International Import Expo (CIIE) is being held in Shanghai from November 5 to 10, showcasing 461 new products, technologies, and services across six major exhibition areas, emphasizing the importance of international trade cooperation and mutual benefits [1][2] - Amway China is leveraging the CIIE to highlight its commitment to health products and services, showcasing innovative solutions to meet the diverse health needs of the public [2][3] Group 1: CIIE Overview - The CIIE serves as a platform for global enterprises to tap into the Chinese market, promoting international economic cooperation and injecting positive energy into both the Chinese and global economies [1] - The event features new themes such as the silver economy, ice and snow economy, and sports economy, along with new consumption platforms focusing on digital and health consumption [1] Group 2: Amway's Commitment and Innovations - Amway China is focusing on health consumption, launching a new multi-vitamin and mineral powder product, "Little Gold Powder," which is the first "blue hat" multi-nutrient product in the Chinese market [3] - The company is showcasing a range of anti-aging products aimed at improving health expectancy, including solutions for cellular health, mobility, brain function, and skin health [3] Group 3: Research and Development - Amway has established a plant research center in Wuxi, integrating traditional Chinese medicine with modern biomedical approaches through its "Shennong" system, which includes extensive data on herbal remedies and health solutions [4] - The company is building a comprehensive local research and development system for traditional Chinese medicine, collaborating with various institutions to innovate and modernize agricultural practices [4] Group 4: Investment Plans - Amway has initiated a five-year investment plan of 2.1 billion RMB (approximately 0.3 billion USD) from 2023 to 2027, focusing on upgrading production facilities, enhancing digital infrastructure, and expanding experience centers [6] - The investment plan aims to strengthen Amway's supply chain and innovation capabilities in China, reinforcing its position as a strategic growth engine [6] Group 5: Strategic Alignment - Amway's strategies align with China's national goals of health and well-being, emphasizing digital infrastructure upgrades and a robust supply chain to support the health and wellness sector [7] - The company has successfully transitioned to a "second entrepreneurship" in China, with innovations and business models developed in China being adopted in other markets [7]

Core Insights - The China International Import Expo (CIIE) is increasingly recognized as a platform for promoting international trade cooperation and mutual benefits, contributing positively to both the Chinese and global economies [1] Company Highlights - Amway, celebrating 30 years in China, showcased its health products and services at the CIIE, addressing the diverse health needs of the public through innovative solutions and research achievements [2] - Amway's Chairman and President, Yu Fang, emphasized the expo's role in enhancing global companies' confidence in investing in China, positioning the country as a strategic market for Amway [4] - Amway launched a new product, a multi-vitamin and mineral powder called "Little Gold Powder," aimed at addressing nutritional imbalances in the Chinese diet, marking it as the first "blue hat" multi-nutrient powder in the market [5] Product Innovations - Amway presented a range of anti-aging products focused on improving healthspan, utilizing plant-based nutrients to enhance quality of life [7] - The company also highlighted products targeting metabolic health, dietary balance, and weight management, showcasing a comprehensive approach to health solutions [8] - Amway's Nutrilite brand is centered on plant nutrients, with significant investments in research and development, including a plant research center in Wuxi and the integration of AI technology for product development [8][10] Investment and Growth Strategy - Amway has initiated a five-year investment plan of 2.1 billion yuan (approximately 300 million USD) from 2023 to 2027, focusing on upgrading production facilities, digital infrastructure, and enhancing research capabilities [13] - The company aims to strengthen its supply chain and innovation capabilities in China, reinforcing its position as a strategic growth engine [14] - Amway's long-term commitment to the Chinese market is evident, with a focus on aligning its development with national strategies for health and well-being [12][14]

Financial Data and Key Metrics Changes - The company reported Q3 2025 revenue of $364 million, which was within the guidance range, and EPS of 34 cents at the higher end of the guidance range [3][14] - Gross margin improved to 70.5% from 70.1% in the prior year, with the core Nu Skin business gross margin at 77.7%, up 120 basis points year-over-year [15][16] - Operating margin for the quarter was 5.9%, up from 4.2% in the prior year, marking continued year-over-year improvement [16] Business Line Data and Key Metrics Changes - Latin America experienced exceptional growth at 53% year-over-year, demonstrating the potential of the emerging market strategy [3][4] - The RISE segment performed as anticipated, with LifeDNA exceeding expectations [4][18] - The core Nu Skin business saw a gross margin of 77.7%, benefiting from strategic portfolio optimization and product mix improvements [15] Market Data and Key Metrics Changes - The intelligent wellness wearables market reached $84 billion in 2024, with significant growth expected in the nutritional supplements market, projected to grow from nearly $500 billion in 2024 to over $700 billion by 2030 [6][8] - Southeast Asia showed strong sequential growth, particularly in markets like Australia, New Zealand, and Malaysia, while Indonesia remains a key focus due to its large population [39] Company Strategy and Development Direction - The company aims to become the world's leading intelligent beauty, wellness, and lifestyle leadership opportunity platform, with key initiatives including the introduction of Prism IO and expansion into India [3][5] - The strategy includes a digital-first approach in India, leveraging local partnerships and a refined compensation plan to cater to the emerging middle class [11][30] - The company is focused on optimizing its product portfolio and managing selling expenses to enhance profitability [12][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strategic direction and highlighted the importance of disciplined execution and innovation-driven growth [18][44] - The company is optimistic about the potential in India and other emerging markets, anticipating these will become a larger part of core business revenue [12][18] - Management acknowledged ongoing macro-environmental pressures but emphasized the ability to maintain operational discipline and financial resilience [3][14] Other Important Information - The company closed the quarter with $252 million in cash and reduced total debt by $20 million, resulting in an expanded positive net cash position [16] - Cash flow from operations was $27.7 million, reflecting disciplined working capital management [17] Q&A Session Summary Question: Full-year guidance adjustments - Management noted the tightening of revenue guidance and the increase in EPS guidance, attributing this to the adoption of Prism IO and the pre-market opening in India [22][24] Question: Launch logistics in India - The company is initiating a pre-market opening in India to acquire revenue and build the sales force, focusing on a digital-first model and local product offerings [27][30] Question: Impact of government shutdown on North America - Management indicated that North America has been less impacted by the government shutdown, but ongoing regulatory work within direct selling is closely monitored [32] Question: Growth in Southeast Asia - The growth in Southeast Asia is attributed to strong performance in markets like Australia and New Zealand, with a focus on local populations in Indonesia [39]

Core Viewpoint - The meeting focused on how the direct selling industry can contribute to rural revitalization, summarizing practical achievements and exploring new paths for empowering rural industries, livelihoods, and governance [1][29]. Group 1: Industry Insights - The direct selling industry has natural advantages in connecting urban and rural areas, with a broad channel network and efficient business models [3]. - Compliance with regulations such as the Direct Selling Management Regulations and the Anti-Pyramid Selling Regulations is essential for the industry's healthy development [3]. - The industry has shown significant achievements in green development, technological innovation, and digital transformation, which need to be further leveraged [7]. Group 2: Report Release - The "China Direct Selling Industry Supporting Rural Revitalization Report (2025 Edition)" was released, covering nearly 40 direct selling companies and analyzing their unique roles in rural development [9][11]. - The report identifies three main values: economic (exploiting rural industry potential), social (creating local employment), and long-term development (activating industry and talent potential) [13]. - It outlines three advantages: addressing agricultural product sales challenges, enhancing product value through brand building, and training new types of professional farmers [13]. Group 3: Practical Paths - The report specifies six practical paths for industry involvement: industry support, talent cultivation, health assistance, ecological protection, technological innovation, and organizational leadership [14]. - Companies shared diverse case studies demonstrating their commitment to rural revitalization, highlighting initiatives in health, technology, and industry integration [15]. Group 4: Company Contributions - Amway focuses on children's health in rural areas, implementing projects that have benefited over 5.1 million children [15][17]. - Infinitus has established 78 herbal medicine planting bases, contributing to an annual increase in farmers' income by 23.4 million yuan [17]. - Ideal Hualai has created a full industry chain in the Anhua black tea sector, helping over 40,000 people escape poverty [19]. - Jiangsu Anhui Biotech has partnered with over 6,000 farmers, achieving an average annual income increase of over 30,000 yuan per household [20]. Group 5: Future Directions - Companies expressed intentions to establish long-term mechanisms for industry support, ensuring compliance and effective contributions to rural revitalization [27]. - The meeting established a collaborative platform involving government guidance, corporate participation, and media oversight to enhance the industry's role in national rural revitalization strategies [29].